| C014464 | 3,4-dichloroaniline | "3,4-dichloroaniline results in increased expression of PLD5 mRNA" | 24172598 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PLD5 mRNA | 29067470 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of PLD5 mRNA | 26705709 |
| C487081 | belinostat | belinostat results in decreased expression of PLD5 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased mutagenesis of PLD5 gene | 25435355 |
| D004958 | Estradiol | Estradiol results in increased expression of PLD5 mRNA | 20106945 |
| C044887 | beta-methylcholine | beta-methylcholine affects the expression of PLD5 mRNA | 21179406 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of PLD5 mRNA | 25181051 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of PLD5 mRNA | 26079696 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in decreased expression of PLD5 mRNA | 26272509 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of PLD5 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in increased expression of PLD5 mRNA | 27392435 |
| D019422 | Dietary Sucrose | Dietary Sucrose results in increased expression of PLD5 mRNA | 26033743 |
| D004237 | Diuron | Diuron metabolite results in increased expression of PLD5 mRNA | 24172598 |
| C118739 | entinostat | entinostat results in decreased expression of PLD5 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLD5 mRNA" | 27188386 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of PLD5 mRNA | 27392435 |
| D007854 | Lead | Lead affects the expression of PLD5 mRNA | 28903495 |
| C008261 | lead acetate | lead acetate results in decreased expression of PLD5 mRNA | 22613225 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of PLD5 mRNA | 28001369 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of PLD5 mRNA | 23557933 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of PLD5 mRNA | 24780913 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of PLD5 mRNA | 25895662 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of PLD5 mRNA | 23397585 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of PLD5 mRNA | 23724009 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of PLD5 mRNA | 24935251 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PLD5 mRNA | 23179753 |
| C111237 | vorinostat | vorinostat results in increased expression of PLD5 mRNA | 27188386 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of PLD5 mRNA | 24714768 |